Differentiation induced by Achyrocline satureioides (Lam) infusion in PC12 cells

Phytotherapy Research

Volumn 23, Issue 9, 2009, Pages 1263-1269

  Blasina, M F ^a   Vaamonde, L ^a   Morquio, A ^a   Echeverry, C ^a   Arredondo, F ^a   Dajas, F ^a  

^a INSTITUTO DE INVESTIGACIONES BIOLÓGICAS CLEMENTE ESTABLE   (Uruguay)

Author keywords

Achyrocline satureioides (Asteraceae); Differentiation; Flavonoids; Luteolin; PC12; Quercetin

Indexed keywords

FLAVONOID; GROWTH FACTOR; LUTEOLIN; NERVE GROWTH FACTOR; QUERCETIN;

ACHYROCLINE; ACHYROCLINE SATUREIODES; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROTECTION; CELL STRAIN; CONTROLLED STUDY; NEURITE; NONHUMAN; RAT; SPINDLE CELL;

ACHYROCLINE; ANIMALS; CELL DIFFERENTIATION; FLAVONOIDS; NERVE GROWTH FACTORS; NEURITES; PC12 CELLS; QUERCETIN; RATS;

ACHYROCLINE SATUREIOIDES; ASTERACEAE;

EID: 69749088338     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2607     Document Type: Article

References (33)

1. Alexi T, Borlongan CV, Faull RL et al. 2000. Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases. Prog Neurobiol 60: 409-470. (Pubitemid 30058341)
2. Amantea D, Russo R, Bagetta G, Corasaniti MT. 2005. From clinical evidence to molecular mechanisms underlying neuroprotection afforded by estrogens. Pharmacol Res 52: 119-132. (Pubitemid 40828362)
3. Arredondo MF, Blasina F, Echeverry C et al. 2004. Cytoprotection by Achyrocline satureioides (Lam) D.C. and some of its main flavonoids against oxidative stress. J Ethnopharmacol 91: 13-20. (Pubitemid 38270221)
4. Auddy B, Ferreira M, Blasina F et al. 2003. Screening of antioxidant activity of three Indian medicinal plants, traditionally used for the management of neurodegenerative diseases. J Ethnopharmacol 84: 131-138. (Pubitemid 36329154)
5. Behl C. 2005. Oxidative stress in Alzheimer's disease: implications for prevention and therapy. Subcell Biochem 38: 65-78.
6. Bui NT, Konig HG, Culmsee C et al. 2002. p75 neurotrophin receptor is required for constitutive and NGF-induced survival signalling in PC12 cells and rat hippocampal neurones. J Neurochem 81: 594-605. (Pubitemid 34809338)
7. Carney JR, Krenisky JM, Williamson RT, Luo J. 2002. Achyrofuran, a new antihyperglycemic dibenzofuran from the South American medicinal plant Achyrocline satureioides. J Nat Prod 65: 203-205. (Pubitemid 34171183)
8. Dajas F, Rivera-Megret F, Blasina F et al. 2003. Neuroprotection by flavonoids. Braz J Med Biol Res 36: 1613-1620.
9. de Rijk MC, Breteler MM, den Breeijen JH et al. 1997. Dietary antioxidants and Parkinson disease. The Rotterdam Study. Arch Neurol 54: 762-765.
10. De Souza KC, Schapoval EE, Bassani VL. 2002. LC determination of flavonoids: separation of quercetin, luteolin and 3- O-methylquercetin in Achyrocline satureioides preparations. J Pharm Biomed Anal 28: 771-777.
11. Denizot F, Lang R. 1986. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89: 271-277. (Pubitemid 16080782)
12. Golbe LI, Farrell TM, Davis PH. 1988. Case-control study of early life dietary factors in Parkinson's disease. Arch Neurol 45: 1350-1353. (Pubitemid 18279704)
13. Greene LA, Tischler AS. 1976. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 73: 2424-2428.
14. Lazarovici P, Marcinkiewicz C, Lelkes PI. 2006. Cross talk between the cardiovascular and nervous systems: neurotrophic effects of vascular endothelial growth factor (VEGF) and angiogenic effects of nerve growth factor (NGF)-implications in drug development. Curr Pharm Des 12: 2609-2622.
15. Liu JH, Yin F, Zheng XX. 2005. Nardostachys chinensis glycoside induces characteristics of neuronal differentiation in rat pheochromocytoma PC12 cells. Biol Pharm Bull 28: 768-771. (Pubitemid 40879957)
16. Middleton E Jr, Kandaswami C, Theoharides TC. 2000. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52: 673-751.
17. Nemeth K, Piskula MK. 2007. Food content, processing, absorption and metabolism of onion flavonoids. Crit Rev Food Sci Nutr 47: 397-409. (Pubitemid 46676538)
18. Orgogozo JM, Dartigues JF, Lafont S et al. 1997. Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev Neurol (Paris) 153: 185-192. (Pubitemid 27262834)
19. Park OJ, Surh YJ. 2004. Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies. Toxicol Lett 150: 43-56.
20. Pechan P, Cizkova D, Murgacova M, Malatova Z. 1991. Effect of nerve growth factor on lesioned PC12 cells. Cell Biol Int Rep 15: 527-535.
21. Polydoro M, de Souza KC, Andrades ME et al. 2004. Antioxidant, a pro-oxidant and cytotoxic effects of Achyrocline satureioides extracts. Life Sci 74: 2815-2826. (Pubitemid 38402098)
22. Ramos S. 2007. Effects of dietary flavonoids on apoptotic pathway related to cancer chemoprevention. J Nutr Biochem 18: 427-442. Epub. (Pubitemid 46874924)
23. Sagara Y, Vanhnasy J, Maher P. 2004. Induction of PC12 cell differentiation by flavonoids is dependent upon extracellular signal-regulated kinase activation. J Neurochem 90: 1144-1155. (Pubitemid 39167347)
24. Sampath D, Jackson GR, Werrbach-Perez K, Perez-Polo JR. 1994. Effects of nerve growth factor on glutathione peroxidase and catalase in PC12 cells. J Neurochem 62: 2476-2479. (Pubitemid 24179533)
25. Simoes CM, Schenkel EP, Bauer L, Langeloh A. 1988. Pharmacological investigations on Achyrocline satureioides (Lam.) DC., Compositae. J Ethnopharmacol 22: 281-293. (Pubitemid 18100573)
26. Singleton VL, Rossi JAJ. 1965. Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Am J Enol Viticult 16: 144-158.
27. Tabakman R, Jiang H, Shahar I, Arien-Zakay H, Levine RA, Lazarovici P. 2005. Neuroprotection by NGF in the PC12 in vitro OGD model: involvement of mitogen-activated protein kinases and gene expression. Ann N Y Acad Sci 1053: 84-96. (Pubitemid 43031085)
28. Takahashi T, Kobori M, Shinmoto H, Tsushida T. 1998. Structure-activity relationships of flavonoids and the induction of granulocytic- or monocytic-differentiation in HL60 human myeloid leukemia cells. Biosci Biotechnol Biochem 62: 2199-2204. (Pubitemid 128473795)
29. 2 in PC12 cells: mechanisms via MMP, ROS, and Bcl-2. Brain Res 1057: 57-64.
30. Wang ZJ, Nie BM, Chen HZ, Lu Y. 2006. Panaxynol induces neurite outgrowth in PC12D cells via cAMP- and MAP kinase-dependent mechanisms. Chem Biol Interact 159: 58-64. (Pubitemid 41773630)
31. Williams RJ, Spencer JP, Rice-Evans C. 2004. Flavonoids: anti-oxidants or signalling molecules? Free Radic Biol Med 36: 838-849.
32. Wollenweber E. 1988. Occurrence of flavonoid aglycones in medicinal plants. Prog Clin Biol Res 280: 45-55.
33. Youdim KA, Spencer JP, Schroeter H, Rice-Evans C. 2002. Dietary flavonoids as potential neuroprotectants. Biol Chem 383: 503-519.